These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ENZYME DEFECTS IN THE HUMAN RED CELL. BARNARD DR BMQ; 1964 Dec; 15():155-74. PubMed ID: 14233004 [No Abstract] [Full Text] [Related]
4. ENZYMES IN MENTAL RETARDATION. ROSANOVA AR; NEIMEYER H; COMPALL T; MICHAELSON AS IMJ Ill Med J; 1964 Jul; 126():52-6. PubMed ID: 14183323 [No Abstract] [Full Text] [Related]
5. IMPLICATIONS ON ENZYME INDUCTION FOR DRUG THERAPY. BURNS JJ Am J Med; 1964 Sep; 37():327-31. PubMed ID: 14218162 [No Abstract] [Full Text] [Related]
6. ENZYMATIC ACTIVITY OF LEUKOCYTES FROM NORMAL AND FROM TUBERCULOUS SUBJECTS. ALLISON MJ; GERSZTEN E; BRUMMER DL; CARTER S Am Rev Respir Dis; 1965 May; 91():713-8. PubMed ID: 14280944 [No Abstract] [Full Text] [Related]
7. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Ingelman-Sundberg M; Rodriguez-Antona C Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1563-70. PubMed ID: 16096104 [TBL] [Abstract][Full Text] [Related]
9. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport. Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342 [TBL] [Abstract][Full Text] [Related]
10. RELATIONSHIP BETWEEN ENZYME IMBALANCE AND THE AGING PROCESS. RICCITELLI ML; WEISS J J Am Geriatr Soc; 1965 May; 13():469-74. PubMed ID: 14284669 [No Abstract] [Full Text] [Related]
11. ENZYMES AS THERAPEUTIC AGENTS. BARBORIAK JJ Wis Med J; 1965 Apr; 64():165-7. PubMed ID: 14272947 [No Abstract] [Full Text] [Related]
12. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety. Lu AY Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931 [TBL] [Abstract][Full Text] [Related]
13. [ARE FOOD ASSIMILATION DISORDERS IN LIVER CIRRHOSIS INFLUENCED BY THE ADMINISTRATION OF PANCREATIC ENZYMES?]. BECK K; SICKINGER R; GNAUCK R Med Klin; 1964 Jul; 59():1243-5. PubMed ID: 14243305 [No Abstract] [Full Text] [Related]
14. [EFFECTS OF AND DANGERS IN ENZYME THERAPY]. YAMAMURA Y Nihon Ishikai Zasshi; 1964 May; 51():1664-9. PubMed ID: 14157059 [No Abstract] [Full Text] [Related]
15. [CLINICAL EXPERIMENTATION ON THE ACTION OF A NEW DIGESTIVE AGENT]. POLETTI G; ROATTA L Minerva Gastroenterol; 1964; 10():190-8. PubMed ID: 14247981 [No Abstract] [Full Text] [Related]
16. [Basic problems and tasks of clinical pharmacogenetics]. Skakun NP Klin Med (Mosk); 1980 Jan; 58(1):11-6. PubMed ID: 6988636 [No Abstract] [Full Text] [Related]
17. [EXPERIENCES IN GENERAL PRACTICE WITH THE TREATMENT OF DIGESTIVE INSUFFICIENCIES WITH ENZYM-MEDICE]. LIEB T Hippokrates; 1964 Sep; 35():693-4. PubMed ID: 14325436 [No Abstract] [Full Text] [Related]
18. THE ANTIVIRAL CHEMOTHERAPEUTIC AGENTS AND THE TRENDS IN ENZYME MEDICATION. BARR M Mil Med; 1964 Jul; 129():629-36. PubMed ID: 14199986 [No Abstract] [Full Text] [Related]
19. [ON THE IMPORTANCE OF SUBSTITUTE THERAPY IN SYNDROMES DUE TO ALTERED ABSORPTION. EXPERIENCES CONDUCTED WITH A NEW DRUG ASSOCIATION]. GRANDONICO F; CITI S Minerva Gastroenterol; 1965; 11():28-32. PubMed ID: 14310471 [No Abstract] [Full Text] [Related]